TNFRSF17 and Miyoshi myopathy: YLMFLLRKI peptide has a powerful HLA-A2-linking affinity with enhanced immunogenicity with respect to the original BCMA72-80 peptide and provokes a strong BCMA-specific memory CD8+ CTL response against MM cells (Figure 3).